NDC 81968-045

AUVELITY

Dextromethorphan Hydrobromide, Bupropion Hydrochloride

AUVELITY is a Oral Tablet, Multilayer, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Axsome Therapeutics, Inc.. The primary component is Bupropion Hydrochloride; Dextromethorphan Hydrobromide.

• Product ID: 81968-045_2a8f1d11-4605-4bde-906f-e99165721141
• NDC: 81968-045
• Product Type: Human Prescription Drug
• Proprietary Name: AUVELITY
• Generic Name: Dextromethorphan Hydrobromide, Bupropion Hydrochloride
• Dosage Form: Tablet, Multilayer, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2022-08-18
• Marketing Category: NDA /
• Application Number: NDA215430
• Labeler Name: Axsome Therapeutics, Inc.
• Substance Name: BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
• Active Ingredient Strength: 105 mg/1; mg/1
• Pharm Classes: Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 81968-045-30

30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-045-30)

• Marketing Start Date: 2022-08-18
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details